Clinical Trials Directory

Trials / Conditions / Relapsed Pediatric ALL

Relapsed Pediatric ALL

8 registered clinical trials studyying Relapsed Pediatric ALL — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingCD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic C
NCT07257419
St. Jude Children's Research HospitalPhase 1
RecruitingBridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for
NCT06581081
Peking University People's HospitalN/A
RecruitingA Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
NCT05334823
Chongqing Precision Biotech Co., LtdPhase 2
RecruitingAnti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refra
NCT03938987
University of AlbertaPhase 1 / Phase 2
UnknownTCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia
NCT04033627
Shanghai Children's Medical CenterN/A
CompletedLow Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia
NCT04562792
Children's Mercy Hospital Kansas CityPhase 2
CompletedPhase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolesce
NCT04888468
Chongqing Precision Biotech Co., LtdPhase 1
TerminatedABT-751 With Chemotherapy for Relapsed Pediatric ALL
NCT00439296
Therapeutic Advances in Childhood Leukemia ConsortiumPhase 1 / Phase 2